title: Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
abstract: This article outlines the anesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. This includes a discussion of preoperative evaluation, hemodynamic monitoring, fluid and electrolyte therapy, and temperature management. An understanding of the unique physiologic consequences of this procedure is essential to ensure good outcomes and avoid patient injuries.
authors.affiliation: Department of Anesthesiology, Saint Agnes Hospital, Baltimore, MD 21229, USA. krothfiel@stagnes.org
authors.forename: Kenneth P
authors.initials: KP
authors.lastname: Rothfield
authors.forename: Kathy
authors.initials: K
authors.lastname: Crowley
mesh_terms: D000768:Anesthesia, General / Q000009:adverse effects* / Q000379:methods; D000971:Antineoplastic Combined Chemotherapy Protocols; D002277:Carcinoma / Q000188:drug therapy / Q000601:surgery*; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D003102:Colloids; D003131:Combined Modality Therapy; D000077324:Crystalloid Solutions; D005440:Fluid Therapy; D006439:Hemodynamics; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D007263:Infusions, Parenteral / Q000379:methods*; D007552:Isotonic Solutions; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000601:surgery*
chemical_list: D003102:Colloids; D000077324:Crystalloid Solutions; D007552:Isotonic Solutions